[1]徐洪兰,田瑞民.不同血清乙肝病毒DNA水平对乙肝患者肝功能指标及乙肝标志物的影响[J].医学信息,2024,37(12):119-122.[doi:10.3969/j.issn.1006-1959.2024.12.026]
　XU Hong-lan,TIAN Rui-min.Effects of Different Serum HBV DNA Levels on Liver Function Indexes and Hepatitis B Markers in Patients with Hepatitis B[J].Journal of Medical Information,2024,37(12):119-122.[doi:10.3969/j.issn.1006-1959.2024.12.026]
点击复制

不同血清乙肝病毒DNA水平对乙肝患者肝功能指标及乙肝标志物的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年12期
页码:
119-122
栏目:
论著
出版日期:
2024-06-15

文章信息/Info

Title:
Effects of Different Serum HBV DNA Levels on Liver Function Indexes and Hepatitis B Markers in Patients with Hepatitis B
文章编号:
1006-1959（2024）11-0119-04
作者:
徐洪兰; 田瑞民
（1.天津大学医院检验科，天津 300072；2.天津市第二人民医院急诊科，天津 300192）
Author(s):
XU Hong-lan; TIAN Rui-min
(1.Laboratory Department of University Hospital,Tianjin University,Tianjin 300072,China)2.Emergency Department of Tianjin Second People’s Hospital,Tianjin 300192,China)
关键词:
乙肝病毒DNA; 乙肝; 肝功能指标; 乙肝标志物
Keywords:
Hepatitis B virus DNA; Hepatitis B; Liver function index; Hepatitis B markers
分类号:
R512.6+2
DOI:
10.3969/j.issn.1006-1959.2024.12.026
文献标志码:
A
摘要:
目的 研究不同血清乙肝病毒DNA水平对乙肝患者肝功能指标及乙肝标志物的影响。方法 选取2000年1月-2022年1月天津市第二人民医院诊治的356例乙肝患者作为观察组，依据病毒载量水平将观察组分为A组（＜5.0×102 kU/L）、B组（5.0×102~1.0×104 kU/L）、C组（1.0×104~1.0×106 kU/L）、D组（1.0×106~1.0×108 kU/L），并选取同期在天津市第二人民医院体检健康者356例作为对照组，比较各组肝功能指标 [天冬氨酸转氨酶（AST）、丙氨酸转氨酶（ALT）]水平，并分析观察组中不同乙肝标志物（HBV-M）模式乙肝患者HBV-DNA阳性检出率和DNA含量，另采用Pearson相关性分析HBV－M定量与HBV-DNA载量、肝功能指标的关系。结果 观察组AST、ALT水平均高于对照组（P＜0.05）；不同HBV-DNA病毒载量乙肝患者AST、ALT水平比较，差异有统计学意义（P＜0.05），且D组＞C组＞B组＞A组；不同HBV-M模式乙肝患者HBV-DNA阳性检出率、DNA含量比较，差异有统计学意义（P＜0.05）；Pearson相关性分析显示，HBsAg阳性与AST、ALT无相关性（P＞0.05），与HBV-DNA载量呈正相关（P＜0.05）；HBeAg、HBeAb阳性与HBV-DNA载量、AST呈正相关（P＜0.05），与ALT无相关性（P＞0.05）；HBcAb阳性与HBV-DNA载量、ALT、AST均呈正相关（P＜0.05）。结论 不同血清乙肝病毒DNA水平对乙肝患者肝功能指标及乙肝标志物具有一定的影响，肝功能指标会随乙肝病毒DNA的复制不断升高，乙肝标志物定量检测可评估乙肝体内病毒复制情况，两者联合检测有助于及早发现患者肝功能损伤，从而为临床制定治疗方案提供可靠的依据。
Abstract:
Objective To study the effects of different serum hepatitis B virus DNA levels on liver function indexes and hepatitis B markers in hepatitis B patients.Methods A total of 356 patients with hepatitis B diagnosed and treated in Tianjin Second People’s Hospital from January 2000 to January 2022 were selected as the observation group. According to the level of viral load, the observation group was divided into group A (<5.0×102 kU/L), group B (5.0×102-1.0×104 kU/L), group C (1.0×104-1.0×106 kU/L), group D (1.0×106-1.0×108 kU/L), and 356 healthy people in Tianjin Second People’s Hospital during the same period were selected as the control group. The levels of liver function indexes [aspartate aminotransferase (AST), alanine aminotransferase (ALT)] in each group were compared, and the positive detection rate of HBV-DNA and DNA content in hepatitis B patients with different hepatitis B markers (HBV-M) in the observation group were analyzed. Pearson correlation was used to analyze the relationship between HBV-M quantification and HBV-DNA load and liver function indexes.Results The levels of AST and ALT in the observation group were higher than those in the control group (P<0.05). There were significant differences in AST and ALT levels among patients with different HBV-DNA viral loads (P<0.05), and group D>group C>group B>group A. There were statistically significant differences in HBV-DNA positive detection rate and DNA content among hepatitis B patients with different HBV-M models (P<0.05). Pearson correlation analysis showed that HBsAg positive was not correlated with AST and ALT (P>0.05), but positively correlated with HBV-DNA load (P<0.05); HBeAg and HBeAb positive were positively correlated with HBV-DNA load and AST (P<0.05), but not with ALT (P>0.05); HBcAb positive was positively correlated with HBV-DNA load, ALT and AST (P<0.05).Conclusion Different serum hepatitis B virus DNA levels have certain effects on liver function indexes and hepatitis B markers in hepatitis B patients. Liver function indexes will continue to increase with the replication of hepatitis B virus DNA. Quantitative detection of hepatitis B markers can evaluate the replication of hepatitis B virus in vivo. The combined detection of the two is helpful for early detection of liver function damage in patients, so as to provide a reliable basis for clinical treatment.

参考文献/References:

[1]马苓,牛俊奇.中度病毒载量的慢性乙型肝炎患者高水平乙型肝炎核心相关抗原与肝细胞癌风险增加相关[J].临床肝胆病杂志,2020,36(2):138.[2]肖丽,李阳,杨秀珍,等.低乙型肝炎病毒载量e抗原阴性的慢性乙型肝炎病毒感染者的肝组织学研究[J].中华传染病杂志,2018,36(11):648-653.[3]王闪,鲍瑞玲,李冰,等.肝脏Fibroscan检测参数与慢性乙型肝炎患者肝纤维化程度及肝功能指标的相关性[J].慢性病学杂志,2020,21(5):70-71.[4]刘素华.乙型肝炎患者血清病毒复制指标(HBVDNA)与乙肝标志物及肝功能关系分析[J].医学检验与临床,2018,29(5):14-17.[5]郭强,赵科孝.HBeAg阴性慢性乙肝合并肝硬化患者血清 HBV DNA 水平与肝功能的相关性[J].海南医学,2019,30(8):973-976.[6]李仁杰,徐灵,张宇亮,等.乙型肝炎患者病毒复制指标与乙肝标志物及肝功能关系分析[J].临床和实验医学杂志,2017,16(3):225-227.[7]张玲,郑荣,何三军,等.慢性乙型肝炎患者 HBV-DNA 载量、肝功能指标与免疫学标志物的相关性研究[J].检验医学与临床,2020,17(22):3348-3350.[8]段梦夕,谷娅楠,于淼琛,等.慢性乙型肝炎患者HBeAg与抗-HBe双阳性的原因与临床意义[J].中华医院感染学杂志,2017,27(19):4332-4335.[9]杨志,潘飞燕.乙型肝炎病毒核酸检测在抗病毒治疗中的应用价值[J].实用检验医师杂志,2021,13(1):62-64.[10]中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版)[J].中华传染病杂志,2019,37(12):711-736.[11]袁媛,陈骥,王亚莉.HBeAg阴性慢性乙肝合并肝硬化患者血清HBV-DNA水平与肝功能的关系[J].山东医药,2017,57(1):81-83.[12]王斌,黄汉菊.乙肝病毒血清标志物与HBV DNA载量及肝功能指标的关联性[J].华中科技大学学报(医学版),2017,46(2):214-219.[13]余晓川,毛怀凤,王婷,等.300例藏族慢性乙肝患者血清标本乙肝病毒DNA定量与免疫学标志物检测的对比分析[J].标记免疫分析与临床,2019,26(8):1334-1337.[14]邹红霞,王金环,崔海玲,等.乙型肝炎异常血清学诊断模式与HBV-DNA载量的相关性研究[J].国际病毒学杂志,2017,24(4):239-242.[15]金速速,陈占国,余坚,等.高敏乙型肝炎病毒脱氧核糖核酸定量检测在低病毒载量患者治疗监测中的应用[J].疾病监测,2018,33(1):67-71.[16]谷九莲,刘守胜,李昌飞,等.高灵敏度血清病毒学指标检测在低病毒载量乙型肝炎人群中的应用价值[J].临床肝胆病杂志,2018,34(6):1302-1307.[17]王煜,马娟,张旭,等.慢性乙型肝炎患者STING表达与病毒载量及肝组织病理的相关性[J].中华医院感染学杂志,2020,30(1):82-85.[18]黄丹,陆伟,汪洁,等.天冬氨酸转氨酶/胆碱酯酶比值预测慢性乙型肝炎肝纤维化程度的性能评价[J].同济大学学报(医学版),2018,39(1):76-82.[19]肖丽,李阳,杨秀珍,等.低乙型肝炎病毒载量e抗原阴性的慢性乙型肝炎病毒感染者的肝组织学研究[J].中华传染病杂志,2018,36(11):648-653.[20]王闪,鲍瑞玲,李冰,等.肝脏Fibroscan检测参数与慢性乙型肝炎患者肝纤维化程度及肝功能指标的相关性[J].慢性病学杂志,2020,21(5):702-703.

相似文献/References:

[1]方志军.实时荧光PCR检测乙肝病毒DNA的效果评价[J].医学信息,2019,32(22):175.[doi:10.3969/j.issn.1006-1959.2019.22.062]
　FANG Zhi-jun.Evaluation of the Effect of Real-time Fluorescent PCR on Detection of Hepatitis B Virus DNA[J].Journal of Medical Information,2019,32(12):175.[doi:10.3969/j.issn.1006-1959.2019.22.062]
[2]蔡剑梅,莫素娟,李妙芳.心理护理应用于乙肝肝硬化失代偿期患者的效果[J].医学信息,2020,33(20):174.[doi:10.3969/j.issn.1006-1959.2020.20.055]
　CAI Jian-mei,MO Su-juan,LI Miao-fang.Effect of Psychological Nursing Applied to Patients with Decompensated Hepatitis B Liver Cirrhosis[J].Journal of Medical Information,2020,33(12):174.[doi:10.3969/j.issn.1006-1959.2020.20.055]
[3]唐梦怡,丁永年,柯 月,等.瞬时弹性成像在乙肝肝硬化中的诊断价值及其影响因素[J].医学信息,2020,33(22):100.[doi:10.3969/j.issn.1006-1959.2020.22.028]
　TANG Meng-yi,DING Yong-nian,KE Yue,et al.The Diagnostic Value and Influencing Factors of Transient Elastography in Hepatitis B Liver Cirrhosis[J].Journal of Medical Information,2020,33(12):100.[doi:10.3969/j.issn.1006-1959.2020.22.028]
[4]黄丽玲,吴春城,梁惠卿,等.血清标志物壳多糖酶3样蛋白1评价肝纤维化的研究[J].医学信息,2021,34(10):32.[doi:10.3969/j.issn.1006-1959.2021.10.009]
　HUANG Li-ling,WU Chun-cheng,LIANG Hui-qing,et al.Serum Marker Chitinase 3-like Protein 1 in the Evaluation of Liver Fibrosis[J].Journal of Medical Information,2021,34(12):32.[doi:10.3969/j.issn.1006-1959.2021.10.009]
[5]杨伦辉,戴红妹.不同免疫检验法对乙肝病毒感染血清标志物检验效果的影响[J].医学信息,2024,37(15):142.[doi:10.3969/j.issn.1006-1959.2024.15.033]
　YANG Lun-hui,DAI Hong-mei.Effect of Different Immunoassays on the Detection of Serum Markers of Hepatitis B Virus Infection[J].Journal of Medical Information,2024,37(12):142.[doi:10.3969/j.issn.1006-1959.2024.15.033]

更新日期/Last Update: 1900-01-01